Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Mikrochim Acta ; 190(12): 493, 2023 11 30.
Article in English | MEDLINE | ID: mdl-38032374

ABSTRACT

Water-soluble, stable, and monodisperse palladium nanoclusters (PdNCs) were synthesized using NaBH4 as a reductant and lipoic acid as a ligand. PdNCs, measured by high-resolution transmission electron microscopy, showed a round shape and a diameter of 2.49 ± 0.02 nm. It was found that each PdNC contains 550 Pd atoms on average. These PdNCs offer high amplification as a label of biochemical reactions when inductively coupled plasma-mass spectrometry (ICP-MS) is used as a detector. In addition, PdNCs have catalytic activity on electrochemical reactions, allowing detection by linear sweep voltammetry (LSV). As a proof of applicability, a competitive immunoassay based on PdNC labels was developed for the determination of glial fibrillary acidic protein (GFAP) in human serum, comparing ICP-MS and LSV detection. GFAP is a biomarker for differentiating between patients with ischemic stroke (IS) and hemorrhagic stroke (HS). The limit of detection (LoD), corresponding to IC10 (4-parameter logistic curve), was 0.03 pM of GFAP, both by ICP-MS and LSV, being lower than the 0.31 pM LoD provided by the ELISA commercial kit. Using the error profile method, 0.03 pM and 0.11 pM LoDs were obtained respectively by ICP-MS and LSV: LoD is lower by ICP-MS due to the better precision of the measurements. The analyses of human serum samples from IS, HS, and control (CT) donors using PdNC labels and detection by ICP-MS and LSV were validated with a commercial ELISA kit (for CT donors only ICP-MS provided enough sensitivity). Results point out toward the future use of PdNCs as a label in other immunoprobes for the determination of specific proteins requiring very low LoDs as well as the development of electrochemical decentralized methodologies.


Subject(s)
Palladium , Stroke , Humans , Glial Fibrillary Acidic Protein , Stroke/diagnosis , Enzyme-Linked Immunosorbent Assay , Mass Spectrometry
2.
Clin Neuroradiol ; 32(4): 971-977, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35416489

ABSTRACT

BACKGROUND: Mechanical thrombectomy is the standard of care for acute ischemic stroke due to large-vessel occlusion; however, mechanical thrombectomy fails to achieve adequate recanalization in nearly one third of these cases. Rescue therapy using two stentrievers simultaneously yields good results in clots refractory to single stentriever treatment. We aimed to determine the safety and efficacy of first-line double stentriever thrombectomy for acute occlusion of the M1 segment of the middle cerebral artery and/or terminal internal carotid artery (TICA). METHODS: This single-center study prospectively enrolled consecutive patients with a single M1/TICA occlusion to undergo double stentriever thrombectomy between May and October 2020. Outcomes included successful recanalization (modified thrombolysis in cerebral infarction, TICI 2b/3), first-pass effect, procedure times, number of device passes, symptomatic intracerebral hemorrhage, National Institutes of Health Stroke Scale Score (NIHSS) at discharge, 90-day functional independence (modified Rankin scale 0-2), and 90-day mortality. RESULTS: We analyzed 39 patients median age 79 years (range 42-96 years); 23 (58.9%) female; 19 (48.7%) with TICA occlusions; 5 (12.8%) with mRS 3-5 at admission; mean NIHSS at admission, 17 ± 4.39). Mean time from symptom onset to final angiogram was 238.0 ± 94.6 min; mean intervention duration was 36.0 ± 24.2 min. The mean number of device passes was 1.5 ± 1.07. All patients had final TICI 2b/3, and 27 (69%) had TICI 2c/3 after the first pass. We observed 3 (7.9%) cases of intracerebral symptomatic hemorrhages. At 90 days, 16 (41%) patients were functionally independent and 9 (23%) had died. The percentage of patients with good clinical outcome at 90 days was 55.5% in the first-pass subgroup. CONCLUSION: Our findings suggest that first-line double stentriever thrombectomy is safe and effective for M1/TICA occlusions.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Humans , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Male , Ischemic Stroke/etiology , Stroke/diagnostic imaging , Stroke/surgery , Stroke/etiology , Stents , Treatment Outcome , Retrospective Studies , Thrombectomy/methods , Brain Ischemia/etiology
3.
Interv Neuroradiol ; 26(2): 222-230, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31684785

ABSTRACT

BACKGROUND AND PURPOSE: Acute tandem occlusions often require carotid stenting. Combination of mechanical and pharmacologic therapies in addition to antiplatelet drugs administered to prevent acute stent thrombosis might increase the risk of intracerebral hemorrhage. We present a protocol of antiplatelet regimen based on early post-procedural dual-energy CT (DE-CT). MATERIAL AND METHODS: Fifty consecutive stroke patients with tandem occlusions treated with acute carotid stenting after intracranial thrombectomy and TICI 2b/3 were reviewed. All patients received intravenous lysine acetylsalicylate during the procedure. Dual (aspirin+clopidogrel with or without clopidogrel load, groups A and B, respectively) or mono (aspirin) antiplatelet regimen (group C) was administered 12-24 h later according to brain DE-CT findings. Carotid ultrasonography was performed at 24 h and before discharge. We evaluated the rate of subsequent symptomatic intracranial hemorrhage (SICH) and acute stent thrombosis in each group. RESULTS: Between June 2014 and December 2016, 50 patients were included (mean age 66 years, 76% men, baseline NIHSS 16, median time from symptom onset to recanalization 266 min). According to DE-CT, 24 patients were assigned to group A, 19 to group B and 7 to group C (4 of them had SICH at that time). One patient suffered a subsequent SICH (belonging to group B). There was only one stent thrombosis without clinical repercussions in group B. CONCLUSIONS: DE-CT may contribute to select antiplatelet regimen after acute carotid stenting in tandem occlusions.


Subject(s)
Carotid Stenosis/diagnostic imaging , Carotid Stenosis/drug therapy , Ischemic Stroke/diagnostic imaging , Ischemic Stroke/drug therapy , Platelet Aggregation Inhibitors/therapeutic use , Tomography, X-Ray Computed/methods , Adult , Aged , Aged, 80 and over , Aspirin/analogs & derivatives , Aspirin/therapeutic use , Carotid Stenosis/complications , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/etiology , Clopidogrel/therapeutic use , Female , Humans , Ischemic Stroke/etiology , Lysine/analogs & derivatives , Lysine/therapeutic use , Magnetic Resonance Angiography , Male , Middle Aged , Retrospective Studies , Stents , Thrombectomy , Treatment Outcome
5.
J Stroke Cerebrovasc Dis ; 25(9): 2093-8, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27378732

ABSTRACT

BACKGROUND: Anticoagulated patients (APs) are excluded from the acute stroke management with alteplase in Europe, not in the United States. They could benefit from mechanical thrombectomy (MT), which was not undoubtedly proven. There are scarce data about its results in such patients. The authors' aim is to analyze the efficacy and safety of MT in APs presenting with an acute stroke in our institution. METHODS: Prospective observational study comparing 30 APs and 109 non-anticoagulated patients (N-APs) underwent direct MT without alteplase. Demographic data, clinical severity (National Institutes of Health Stroke Scale [NIHSS]), efficacy (recanalization thrombolysis in cerebral infarction [TICI] ≥ 2b and modified Rankin Scale score ≤ 2 at 3 months), and security (symptomatic intracranial hemorrhage [SICH], mortality at 3 months) were compared between both groups. RESULTS: In both groups men were more frequent (63.3% of APs were men and 61.5% of N-APs were men). Mean age was 73 in APs and 67.2 in N-APs. Median NIHSS was similar (17 APs; 16 N-APs), also TICI greater than or equal to 2b (93.3% APs; 89.9% N-APs). The 3-month modified Rankin Scale score less than or equal to 2 was 46.7% in APs and 55.2% in N-APs (P = .40). SICH was present in 16.7% of APs and 8.3% of N-APs (P = .15). Mortality at 3 months was 6.7% in APs and 19% in N-APs (P = .08). CONCLUSIONS: MT is a valid treatment option in APs. It achieves an efficacy as in N-APs with a tendency to suffer more from SICH, but lower mortality. We hypothesize that cardioembolic clots may be easier to be removed than atherotrombotics, and that embolic stroke in APs might be less severe than that in N-APs or might suffer less of other complications than atherotrombotics.


Subject(s)
Anticoagulants/therapeutic use , Mechanical Thrombolysis/methods , Stroke/therapy , Treatment Outcome , Aged , Aged, 80 and over , Brain Ischemia/complications , Disease Management , Female , Humans , Male , Middle Aged , Prospective Studies , Retrospective Studies , Severity of Illness Index , Statistics, Nonparametric , Stroke/epidemiology
8.
Int Med Case Rep J ; 9: 145-8, 2016.
Article in English | MEDLINE | ID: mdl-27354832

ABSTRACT

BACKGROUND: Stroke mimics may account for up to 30% of all acute stroke consultations. However, in the emergency setting, accurate diagnosis is not always possible. METHODS: Case report and review of the literature. RESULTS: A 73-year-old woman was admitted to the emergency department with acute aphasia and right hemiparesis. The National Institute of Health Stroke Score was 21, compatible with severe stroke, so she received thrombolysis. Laboratory testing demonstrated severe hypomagnesemia. She had been taking proton pump inhibitors for years and neuroimaging did not demonstrate signs of acute ischemic disease. After correcting the metabolic alterations with intravenous and oral supplemental magnesium, the patient was discharged asymptomatic. No further episodes have been registered to date. CONCLUSION: Hypomagnesemia might cause acute neurological symptoms that could be confused with stroke. A careful history is essential for diagnosis but suspicion of stroke mimic should not prevent tPA administration.

9.
BMJ Case Rep ; 20162016 Apr 26.
Article in English | MEDLINE | ID: mdl-27118746

ABSTRACT

With increasing prevalence due to an ageing population, carotid artery stenosis is a significant cause of stroke morbidity and mortality. The indication for revascularisation treatment in symptomatic carotid stenosis is widely documented and accepted in the scientific community. However, treatment of asymptomatic carotid stenosis remains controversial. We report a case of a 78-year-old woman who was admitted with a convexity subarachnoid haemorrhage (cSAH) secondary to an asymptomatic high-grade carotid artery stenosis. Two months later, she suffered an atherothrombotic ischaemic stroke and was referred to surgery. Transcranial Doppler studies showed impaired cerebral vasoreactivity and, after endarterectomy, the patient developed a reperfusion syndrome; both findings consisting of exhausted collaterals as the underlying mechanism. We propose that cSAH secondary to a high-grade internal carotid artery stenosis is a high risk marker for stroke, and revascularisation therapy should be considered.


Subject(s)
Carotid Stenosis/complications , Cerebral Revascularization , Stroke/etiology , Subarachnoid Hemorrhage/etiology , Aged , Endarterectomy, Carotid , Female , Humans , Risk Factors , Stroke/prevention & control , Subarachnoid Hemorrhage/therapy
11.
BMJ Case Rep ; 20152015 Jun 02.
Article in English | MEDLINE | ID: mdl-26038385

ABSTRACT

Periodontal infections might represent one of the causative factors for cervical artery dissection. We present a case of a 49-year-old woman admitted due to headache. The patient had been suffering from a right second inferior molar infection with a cervical phlegmon for 1 week prior to admission. On 2 October 2014, the patient went to the dentist and a molar extraction was performed in the morning. In the afternoon, the patient began to experience right hemifacial pain that progressed towards an intense and bilateral headache. Neurological status at the time of admission revealed right miosis, ptosis and conjuntival hyperaemia. A CT angiography showed a right internal carotid artery dissection provoking a high-degree stenosis. The relationship between periodontal infection and vascular disease has been previously presented. Microbial agents may directly, and inflammatory and immunological host response indirectly, influence inflammatory changes in cervical arteries favouring dissections with minor traumas.


Subject(s)
Carotid Artery, Internal, Dissection/etiology , Molar/surgery , Tooth Diseases/surgery , Tooth Extraction/adverse effects , Anticoagulants/administration & dosage , Carotid Artery, Internal/diagnostic imaging , Carotid Artery, Internal, Dissection/diagnosis , Carotid Artery, Internal, Dissection/drug therapy , Cellulitis/microbiology , Cellulitis/pathology , Female , Headache/diagnosis , Headache/etiology , Headache/microbiology , Heparin, Low-Molecular-Weight/administration & dosage , Humans , Middle Aged , Molar/microbiology , Molar/pathology , Tooth Diseases/microbiology , Tooth Extraction/methods , Treatment Outcome , Ultrasonography
12.
J Stroke Cerebrovasc Dis ; 24(8): e209-11, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25979425

ABSTRACT

A 77-year-old woman with atrial fibrillation (AF) treated with warfarin had a cortical left middle cerebral artery (MCA) stroke (October 2009, international normalized ratio [INR], 1.6) and a cortical left frontal stroke (October 2011, INR, 1.9). Anticoagulation was adjusted. In October 2011, she had a right frontal stroke (INR, 2.3). Acetylsalicylic acid (ASA) was temporally added to the treatment. In June 2013, she had a left occipital stroke (INR, 2.3). Warfarin was changed to rivaroxaban. In August 2013, she had a right occipital stroke. ASA 100 was added to the treatment. On all occasions, repeated neurovascular studies and echocardiography were normal. Diagnoses were cardioembolic stroke. In November 2013, she was admitted because of a left MCA stroke. A complete blood analysis showed the presence of anticardiolipin, anti-b2-glycoprotein antibodies, and lupus anticoagulant. Primary antiphospholipid syndrome (APS) was later confirmed. APS should be considered in young stroke patients, however is not frequent in stroke patients older than 70 years with several cerebrovascular risk factors. The existence of AF in our patient with several embolic strokes made the cardiembolic etiology likely. Uncommon causes of stroke were not considered despite the repetition of the ischemic events. Thus, a wider etiological study should be made in all patients with a recurrent stroke regardless of age, such as a complete blood analysis including immunology study in order to exclude an APS of late onset.


Subject(s)
Antiphospholipid Syndrome/diagnosis , Stroke/diagnosis , Aged , Antiphospholipid Syndrome/complications , Atrial Fibrillation/drug therapy , Female , Humans , Magnetic Resonance Imaging , Rivaroxaban/therapeutic use , Stroke/complications , Warfarin/therapeutic use
13.
Vascular ; 23(2): 211-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24838273

ABSTRACT

INTRODUCTION: Definitive treatment of symptomatic atheromatous internal carotid artery occlusion remains controversial, as far as in rare cases, late spontaneous recanalization has been seen. METHODS: We consecutively studied 182 patients (January 2003 to August 2012) with an ischemic stroke in the internal carotid artery territory and diagnosis of atheromatous internal carotid artery occlusion during hospitalization. FINDINGS: Seven patients presented a late spontaneous recanalization (>3 months) of the internal carotid artery. We described therapeutic attitude according to usual care in these patients. CONCLUSIONS: The authors attempt to highlight the unusual condition of recanalization after a symptomatic atheromatous chronic internal carotid artery occlusion. If these patients can be treated similar to patients with asymptomatic carotid pathology, then this needs to be clarified. However, due to the risk of ipsi- and contralateral ischemic strokes, revascularization techniques should be considered in certain cases. More studies are needed to establish the most appropriate therapeutical approach in order to avoid arbitrary treatment of these patients.


Subject(s)
Carotid Artery Diseases/surgery , Carotid Artery, Internal/surgery , Carotid Stenosis/surgery , Plaque, Atherosclerotic/surgery , Carotid Artery Diseases/diagnosis , Carotid Artery, Internal/pathology , Carotid Stenosis/diagnosis , Humans , Plaque, Atherosclerotic/pathology , Stroke/diagnosis , Stroke/surgery , Treatment Outcome
14.
Int. j. odontostomatol. (Print) ; 8(2): 191-199, set. 2014. ilus
Article in Spanish | LILACS | ID: lil-722886

ABSTRACT

El trauma dentoalveolar (TDA) constituye un conjunto de lesiones que comprometen los dientes o a sus estructuras periodontales. En Chile, desde el año 2007, la primera consulta/tratamiento de urgencia del TDA está cubierta por la Ley N 19.966, para todas las personas afiliadas al Fondo Nacional de Salud (FONASA) y a las Instituciones de Salud Previsional Privadas (ISAPRE) a través del Programa de Garantías Explícitas en Salud (GES). Escasos estudios nacionales se han realizado en TDA de adultos y ninguno en relación al impacto del GES en estas lesiones. Se realizó un estudio retrospectivo, descriptivo y transversal de TDA con los Datos de Urgencia de todos los pacientes adultos atendidos en el Hospital de Urgencia Asistencia Pública. Se compararon las variables clínicas, etiológicas, demográficas y sociales entre 2 períodos: pre-GES (1 de Julio de 2005 al 30 de Junio de 2006) y post-GES (1 de julio de 2012 al 31 junio de 2013). En los 2 períodos se observó una mayor frecuencia de TDA en el sexo masculino del grupo de 20­29 años, producidos en la mayoría de los casos por violencia interpersonal. Sin embargo se observó en el período post-GES una mayor consulta de TDA por Accidente vehículo-motorizado, presentándose lesiones de mayor gravedad. A pesar de la implementación del GES, se observó una alta frecuencia de TDA no tratados, esto podría deberse a la gravedad del estado sistémico del paciente (postergando el tratamiento de TDA), a la falta de insumos o a la inequidad en la entrega de recursos a los servicios de salud. Es necesario realizar más estudios y vigilancia de parte de la autoridad sanitaria para mejorar las garantías del GES en el tratamiento de los TDA.


Traumatic dental injury (TDI) is a group of injuries that affect hard dental tissues and/or periodontal structures. Since 2007 the first emergency treatment/consult of TDI, for both the National Health Fund (FONASA) and profit private insurer (ISAPRE) affiliates, is guaranteed in the Regulation of Explicit Health Guarantees (GES) established by Chilean Law 19.966. Few national TDI studies in adults have been carried out, and none in relation to the impact of GES in this type of lesion. A retrospective cross sectional study of emergency charts of all adult patients attended at the Hospital de Urgencia Asistencia Pública. Etiological, clinical, demographic and social variables were compared between 2 time periods, Pre-GES period (July, 1 2005 to June, 30 June 2006) versus Post-GES period (July, 1 2012 to June, 31 2013). A high incidence of TDI caused by interpersonal violence in males between 20 and 29 years old was observed in both periods. However, an increased TDI with more severe injuries caused by automobile accident was observed during the post-GES period. In spite of GES implementation, high frequency of non-treated TDI was seen in the present study, this could be due to the severity of the patient´s systemic condition (delaying the TDI treatment), a lack of resources and/or inequity in the delivery of these healthcare resources. More studies and surveillance programs by the Government are needed to improve TDI treatment guarantees, and as well as regular assessment of GES compliance.

15.
Neurología (Barc., Ed. impr.) ; 29(6): 353-370, jul.-ago. 2014. tab, graf
Article in Spanish | IBECS | ID: ibc-188070

ABSTRACT

OBJETIVO: Actualización de la guía para el diagnóstico y tratamiento de la hemorragia subaracnoidea de la Sociedad Española de Neurología. MATERIAL Y MÉTODOS: Revisión y análisis de la bibliografía existente. Se establecen recomendaciones en función del nivel de evidencia que ofrecen los estudios revisados. RESULTADOS: La causa más frecuente de hemorragia subaracnoidea espontánea (HSA) es la rotura de un aneurisma cerebral. Su incidencia se sitúa en torno 9 casos por 100.000 habitantes/año y supone un 5% de todos los ictus. La hipertensión arterial y el tabaquismo son sus principales factores de riesgo. Se ha de realizar el tratamiento en centros especializados. Se debe considerar el ingreso en unidades de ictus de aquellos pacientes con HSA y buena situación clínica inicial (grados I y II en la escala de Hunt y Hess). Se recomienda la exclusión precoz de la circulación del aneurisma. El estudio diagnóstico de elección es la tomografía computarizada (TC) craneal sin contraste. Si esta es negativa y persiste la sospecha clínica se aconseja realizar una punción lumbar. Los estudios de elección para identificar la fuente de sangrado son la resonancia magnética (RM) y la angiografía. Los estudios ultrasonográficos son útiles para el diagnóstico y seguimiento del vasoespasmo. Se recomienda el nimodipino para la prevención de la isquemia cerebral diferida. La terapia hipertensiva y el intervencionismo neurovascular pueden plantearse para tratar el vasoespasmo establecido. CONCLUSIONES: La HSA es una enfermedad grave y compleja que debe ser atendida en centros especializados, con suficiente experiencia para abordar el proceso diagnóstico y terapéutico


OBJECTIVE: To update the Spanish Society of Neurology's guidelines for subarachnoid haemorrhage diagnosis and treatment. MATERIAL AND METHODS: A review and analysis of the existing literature. Recommendations are given based on the level of evidence for each study reviewed. RESULTS: The most common cause of spontaneous subarachnoid haemorrhage (SAH) is cerebral aneurysm rupture. Its estimated incidence in Spain is 9/100 000 inhabitants/year with a relative frequency of approximately 5% of all strokes. Hypertension and smoking are the main risk factors. Stroke patients require treatment in a specialised centre. Admission to a stroke unit should be considered for SAH patients whose initial clinical condition is good (Grades I or II on the Hunt and Hess scale). We recommend early exclusion of aneurysms from the circulation. The diagnostic study of choice for SAH is brain CT (computed tomography) without contrast. If the test is negative and SAH is still suspected, a lumbar puncture should then be performed. The diagnostic tests recommended in order to determine the source of the haemorrhage are MRI (magnetic resonance imaging) and angiography. Doppler ultrasonography studies are very useful for diagnosing and monitoring vasospasm. Nimodipine is recommended for preventing delayed cerebral ischaemia. Blood pressure treatment and neurovascular intervention may be considered in treating refractory vasospasm. CONCLUSIONS: SAH is a severe and complex disease which must be managed in specialised centres by professionals with ample experience in relevant diagnostic and therapeutic processes


Subject(s)
Humans , Practice Guidelines as Topic , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/therapy , Brain Ischemia/complications , Cerebral Angiography , Intracranial Aneurysm/complications , Magnetic Resonance Imaging , Nimodipine/therapeutic use , Risk Factors , Subarachnoid Hemorrhage/etiology , Tomography, X-Ray Computed
16.
Neurología (Barc., Ed. impr.) ; 29(3): 168-183, abr. 2014. tab
Article in Spanish | IBECS | ID: ibc-188069

ABSTRACT

FUNDAMENTO Y OBJETIVO: Actualizar las guías terapéuticas del Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN en el tratamiento preventivo de ictus isquémico (II) y ataque isquémico transitorio (AIT). MÉTODOS: Revisión de evidencias disponibles sobre la prevención del ictus isquémico y AIT en función del subtipo etiológico. Los niveles de evidencia y grados de recomendación se han basado en la clasificación del Centro de Medicina Basada en la Evidencia. RESULTADOS: En el II de origen aterotrombótico reducen el riesgo de recurrencias el tratamiento antiagregante y los procedimientos revascularizadores en casos seleccionados de estenosis carotidea ipsilateral (70-99%). La prevención de II de origen cardioembólico (fibrilación auricular, valvulopatías, prótesis valvulares y en infarto de miocardio con trombo mural) se basa en el uso de anticoagulantes orales. En el II de origen inhabitual, las terapias preventivas dependerán de la etiología; en la trombosis venosa cerebral la anticoagulación oral es eficaz. CONCLUSIONES: Se concluye con recomendaciones de práctica clínica en prevención de ictus isquémico y AIT adaptadas al subtipo etiológico de II que ha presentado el paciente


BACKGROUND AND OBJECTIVE: To update the ad hoc Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological Society guidelines on prevention of ischaemic stroke (IS) and Transient Ischaemic Attack (TIA). METHODS: We reviewed the available evidence on ischaemic stroke and TIA prevention according to aetiological subtype. Levels of evidence and recommendation levels are based on the classification of the Centre for Evidence-Based Medicine. RESULTS: In atherothrombotic IS, antiplatelet therapy and revascularization procedures in selected cases of ipsilateral carotid stenosis (70%-90%) reduce the risk of recurrences. In cardioembolic IS (atrial fibrillation, valvular diseases, prosthetic valves and myocardial infarction with mural thrombus) prevention is based on the use of oral anticoagulants. Preventive therapies for uncommon causes of IS will depend on the aetiology. In the case of cerebral venous thrombosis oral anticoagulation is effective. CONCLUSIONS: We conclude with recommendations for clinical practice in prevention of IS according to the aetiological subtype presented by the patient


Subject(s)
Humans , Brain Ischemia/prevention & control , Ischemic Attack, Transient/prevention & control , Stroke/prevention & control , Brain Ischemia/etiology , Evidence-Based Medicine , Ischemic Attack, Transient/classification , Ischemic Attack, Transient/etiology , Stroke/classification , Stroke/etiology
17.
J Neurol Sci ; 336(1-2): 180-3, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24211062

ABSTRACT

UNLABELLED: Two population-based studies have found an increased prevalence of posterior circulation territory (PCT) infarct-like lesions in migraine, which seemed to increase with attack frequency. OBJECTIVE: To determine whether chronic migraine (CM) patients are at increased risk of PCT infarct-like lesions. METHODS: We prospectively obtained brain MRIs from adult women fulfilling CM criteria. To keep radiologists blinded we also obtained brain MRIs in 15 episodic migraine (EM) patients. MRIs were acquired on a 1.5 T unit. Protocol included whole brain weighted images in sagittal T1 (5 mm slices), axial FLAIR T2 (3 mm) and combined proton density and T2 fast spin echo (3 mm). Two independent neuroradiologists carefully analyzed all the images. RESULTS: One hundred women with CM participated. Their ages ranged from 18 to 68 years (mean 43.7) and the length of CM ranged from 0.5 to 38 years (mean 9.8). Sixty-three patients (63%) had at least one vascular risk factor. Thirty-three met analgesic overuse criteria. Fifty-one had a history of migraine with aura attacks, though aura frequency was below one per month in all patients except one. Eleven were not on preventatives. We found PCT infarct-like lesions in only 6 CM patients aged 42-64 years (mean age 54 years) who had at least two vascular risk factors. CONCLUSIONS: As frequency of PCT infarct-like lesions in our CM patients was in the low range than that found for EM in general population studies, we conclude that frequency of migraine attacks itself is not a factor increasing PCT infarct-like lesion risk.


Subject(s)
Cerebral Infarction/diagnosis , Cerebral Infarction/epidemiology , Cerebrovascular Circulation/physiology , Migraine Disorders/diagnosis , Migraine Disorders/epidemiology , Population Surveillance , Adolescent , Adult , Aged , Chronic Disease , Female , Humans , Male , Middle Aged , Population Surveillance/methods , Prospective Studies , Young Adult
18.
Headache ; 54(3): 545-50, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23981007

ABSTRACT

BACKGROUND: Convexal subarachnoid hemorrhage has been associated with different diseases, reversible cerebral vasoconstriction syndrome and cerebral amyloid angiopathy being the 2 main causes. OBJECTIVE: To investigate whether headache at onset is determinant in identifying the underlying etiology for convexal subarachnoid hemorrhage. METHODS: After searching in the database of our hospital, 24 patients were found with convexal subarachnoid hemorrhage in the last 10 years. The mean age of the sample was 69.5 years. We recorded data referring to demographics, symptoms and neuroimaging. RESULTS: Cerebral amyloid angiopathy patients accounted for 46% of the sample, 13% were diagnosed with reversible cerebral vasoconstriction syndrome, 16% with several other etiologies, and in 25%, the cause remained unknown. Mild headache was present only in 1 (9%) of the 11 cerebral amyloid angiopathy patients, while severe headache was the dominant feature in 86% of cases of the remaining etiologies. CONCLUSION: Headache is a key symptom allowing a presumptive etiological diagnosis of convexal subarachnoid hemorrhage. While the absence of headache suggests cerebral amyloid angiopathy as the more probable cause, severe headache obliges us to rule out other etiologies, such as reversible cerebral vasoconstriction syndrome.


Subject(s)
Brain Diseases/complications , Headache/etiology , Subarachnoid Hemorrhage/etiology , Aged , Cerebral Amyloid Angiopathy/complications , Female , Humans , Male , Middle Aged , Vasospasm, Intracranial/complications
19.
BMJ Case Rep ; 20132013 Aug 05.
Article in English | MEDLINE | ID: mdl-23917371

ABSTRACT

In February 2011, the Food and Drug Administration informed that prescription of proton pump inhibitor (PPI) drugs may cause low serum magnesium levels if taken for prolonged periods of time. We present an ex-smoker, 76-year-old man, with high blood pressure, diabetes mellitus and Barrett's oesophagus (treated with esomeprazole since 2003) admitted due to fluctuating aphasia. Neurovascular and neuroimaging studies were normal. Dyslipidemia and atrial arrhythmia were discovered. The patient was discharged with the diagnosis of left middle cerebral artery transient ischaemic attack and anticoagulation treatment was recommended. The patient returned to the emergency department on further two occasions (confusional episodes) and was admitted in order to complete the neurological study that was normal. The patient was discharged with the diagnosis of probable epileptic seizures. After a week, he was admitted due to generalised temblor and unsteadiness. A complete blood test was performed and showed a severe hypomagnesaemia (not previously performed).


Subject(s)
Confusion/chemically induced , Esomeprazole/adverse effects , Magnesium/blood , Metabolic Diseases/complications , Proton Pump Inhibitors/adverse effects , Aged , Humans , Male , Metabolic Diseases/chemically induced , Recurrence
20.
Int Arch Med ; 6(1): 19, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23635082

ABSTRACT

BACKGROUND: Transient ischemic attacks (TIA) entail a high risk of stroke recurrence, which depends on the etiology. New organizational models have been created, but there is not much information about the long-term evolution of patients managed according to these premises. Our aim is to refer the follow-up of patients attended according to our model of TIA Unit. METHODS: TIA Unit is located in the Emergency Department and staffed by vascular neurologists. Patients admitted during the Neurology night shift stayed in such Unit <48h with complete etiological study. Preventive treatment is instituted in patients discharged to a high resolution Neurology consult, in order to review in <2 weeks and subsequent follow-up. RESULTS: During a year 161 patients were attended, being admitted to the hospital 8.6%. A total of 1470 hospital days were avoided. Recurrence at 90 days was of 0.6%. Mean follow-up was 18.14 ± 8.02 months (0-34), total recurrence 6.2% (70% cardioembolic strokes). There were no complications derived from treatment. Cardiological events were recorded in 10.6%, neoplastic in 5%, cognitive impairment in 11%. There were 3 deaths unrelated nor to the stroke or its treatment. CONCLUSIONS: This model allows an early diagnosis and treatment of TIA, preventing recurrences of stroke in a long term. It detects atherothrombotic strokes, most of them admitted to the hospital, and it shows a greater difficulty for detecting all cardioembolic strokes. TIA Unit appeared to be safe in using anticoagulation therapy, as the follow-up shows. It shows the same quality of management than hospital admission, with a significant saving in hospital stays.

SELECTION OF CITATIONS
SEARCH DETAIL
...